View clinical trials related to Neovascularization, Pathologic.
Filter by:The purpose of this study is to determine the ocular and non-ocular safety of a single dose of ranibizumab in treating neovascularization secondary to sickle cell retinopathy.
The purpose of this study is to determine whether topical bevacizumab is safe or not when used in corneal neovascularization for long term period.
The purpose of study is to determine if Lucentis combined with imatinib mesylate will help treatment in patients with newly diagnosed choroidal neovascularization.